Jason Sicklick named co-leader of the Structural and Functional Genomics Research Program at UCSD Moores

Checkpoint therapy breakthrough sparks new vaccine

Immune-checkpoint therapy, which attempts to harness a patient’s own immune system to fight cancer, has revolutionized cancer care over the past two decades.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Individuals with cannabis use disorder are more than three times more likely to develop oral cancer within five years compared to those without CUD, a researcher at the University of California San Diego School of Medicine found.

August 01, 2025

Vol.51 No.30

Clinical Roundup

Study reveals new approach for understanding chromatin’s 3D structure and significance

Spatial mapping experiments reveal that topologically associating domains in individual cells tend to take a globular shape, according to a study conducted by scientists at Sanford Burnham Prebys and colleagues in Hong Kong.

July 18, 2025

Vol.51 No.28

In Brief

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Samra Turajlić was appointed the director of the Cancer Research UK Manchester Institute.

June 20, 2025

Vol.51 No.24

In Brief

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

After serving as the director of the National Human Genome Research Institute for more than 15 years, Eric Green has left his role.

March 21, 2025

Vol.51 No.11

Clinical Trials & Tribulations

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

The definition of “therapeutic imperative” is this: A treatment necessity that must be met in order to prevent death. Once the imperative is clearly defined, addressing it properly links correct diagnosis with therapy and favorable prognosis. On the other hand, misdiagnosis or inadequate diagnosis fails to provide a framework for highly effective or curative therapy.

March 07, 2025

Vol.51 No.09

By Michael P. Castro

Jason Sicklick named co-leader of the Structural and Functional Genomics Research Program at UCSD Moores

YOU MAY BE INTERESTED IN

Checkpoint therapy breakthrough sparks new vaccine

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Study reveals new approach for understanding chromatin’s 3D structure and significance

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Renew today!

Subscriber content

Never miss an issue!

Login